Clinical Trial Update: Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating neoadjuvant FOLFIRINOX for resectable locally advanced rectal cancer has completed, reporting efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: UNICANCER | Conditions: Cancer of the Rectum | Phase 3 | Status: COMPLETED